Galectin Therapeutics Inc(GALT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GALT Galectin Therapeutics Inc

盘前交易 08-21 08:30:50 EDT

3.57

-0.10

-2.72%

盘前3.57

+0.00+0.09%

08:25 EDT

最高3.75	最低3.44	成交量31.31万
今开3.67	昨收3.67	日振幅8.43%
总市值3.61亿	流通市值1.72亿	总股本1.01亿
成交额112.08万	换手率0.65%	流通股本4,817万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GALT","market":"US","secType":"STK","nameCN":"Galectin Therapeutics Inc","latestPrice":3.57,"timestamp":1787256000000,"preClose":3.67,"halted":0,"volume":313109,"hourTrading":{"tag":"盘前","latestPrice":3.5732,"preClose":3.57,"latestTime":"08:25 EDT","volume":1055,"amount":3734.4401534999997,"timestamp":1787315113801,"change":0.0032,"changeRate":0.000896,"amplitude":0.22409},"delay":0,"changeRate":-0.02724795640326978,"floatShares":48165869,"shares":101000000,"eps":-0.430162,"marketStatus":"盘前交易","change":-0.1,"latestTime":"08-21 08:30:50 EDT","open":3.67,"high":3.7493,"low":3.44,"amount":1120784.4677605,"amplitude":0.084278,"askPrice":3.9,"askSize":100,"bidPrice":3.41,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-0.430162,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787319000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1063166400000,"exchange":"NASDAQ","adjPreClose":3.57,"preHourTrading":{"tag":"盘前","latestPrice":3.5732,"preClose":3.57,"latestTime":"08:25 EDT","volume":1055,"amount":3734.4401534999997,"timestamp":1787315113801,"change":0.0032,"changeRate":0.000896,"amplitude":0.22409},"postHourTrading":{"tag":"盘后","latestPrice":3.6765,"preClose":3.57,"latestTime":"19:30 EDT","volume":901,"amount":3208.3765,"timestamp":1787268607261,"change":0.1065,"changeRate":0.029832,"amplitude":0.04916},"volumeRatio":0.8047878743548801,"impliedVol":2.299,"impliedVolPercentile":0.864},"requestUrl":"/m/hq/s/GALT/","defaultTab":"news","newsList":[{"id":"1163469200","title":"Galectin Therapeutics与FDA就Belapectin全面获批的主要终点及监管路径达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1163469200","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163469200?lang=zh_cn&edition=full","pubTime":"2026-06-23 19:54","pubTimestamp":1782215664,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics Inc宣布，已与美国食品药品监督管理局（FDA）就其候选药物Belapectin未来寻求全面批准的主要终点和监管路径达成协议。这一进展为该公司推进该药物的临床开发计划明确了关键方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113047233","title":"Galectin Therapeutics 宣布Belapectin的NAVIGATE二期B阶段试验结果在《肝脏病学杂志》发表","url":"https://stock-news.laohu8.com/highlight/detail?id=1113047233","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113047233?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:02","pubTimestamp":1778500979,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics Inc宣布，其候选药物Belapectin的NAVIGATE二期B阶段临床试验结果，已正式发表于权威期刊《肝脏病学杂志》。该试验旨在评估Belapectin治疗非酒精性脂肪性肝炎伴肝硬化患者的疗效与安全性。研究结果的详细披露，将为后续的临床开发路径提供关键的学术依据。这一里程碑事件，不仅强化了Belapectin作为潜在NASH疗法的科学基础，也提升了Galectin Therapeutics在该领域的能见度。公司将继续推进相关临床项目，以应对这一尚未满足重大医疗需求的疾病领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149526340","title":"Galectin Therapeutics Inc 2025财年普通股股东应占净亏损达3100万美元，合每股亏损0.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149526340","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149526340?lang=zh_cn&edition=full","pubTime":"2026-03-31 20:13","pubTimestamp":1774959197,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics Inc（股票代码：GALT）公布的2025财年财务数据显示，公司全年普通股股东应占净亏损为3100万美元，折合每股亏损0.48美元。这一业绩反映了公司在研发阶段的持续投入以及运营成本的管理情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618968768","title":"Galectin Therapeutics Inc.盘中异动 下午盘急速跳水5.67%报3.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618968768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618968768?lang=zh_cn&edition=full","pubTime":"2026-03-11 02:08","pubTimestamp":1773166132,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日02时08分，Galectin Therapeutics Inc.股票出现异动，股价快速下挫5.67%。截至发稿，该股报3.16美元/股，成交量44.3595万股，换手率0.69%，振幅8.66%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.90%。其相关个股中，Polaryx Therapeutics, Inc.、Longeveron Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Longeveron Inc.、Acurx Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.较为活跃，换手率分别为1100.49%、1003.30%、702.88%，振幅较大的相关个股有Polaryx Therapeutics, Inc.、Longeveron Inc.、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为116.47%、109.01%、60.16%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031102085297ac610b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031102085297ac610b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","BK4539","GALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512571165","title":"Galectin Therapeutics Inc.盘中异动 股价大涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512571165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512571165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889186,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分，Galectin Therapeutics Inc.股票出现波动，股价快速拉升5.67%。截至发稿，该股报1.49美元/股，成交量12.6519万股，换手率0.20%，振幅3.52%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Glycomimetics, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为279.92%、96.82%、73.20%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Solid Biosciences Inc.，振幅分别为34.04%、22.30%、18.61%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223306abd3af86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223306abd3af86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GALT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505568271","title":"Galectin Therapeutics Inc.盘中异动 大幅下挫5.65%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505568271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505568271?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:32","pubTimestamp":1737469936,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时32分，Galectin Therapeutics Inc.股票出现波动，股价大幅跳水5.65%。截至发稿，该股报1.17美元/股，成交量2.8401万股，换手率0.05%，振幅2.42%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223217960bb911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223217960bb911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501564702","title":"Galectin Therapeutics Inc.盘中异动 股价大涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501564702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501564702?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:32","pubTimestamp":1736173971,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时32分，Galectin Therapeutics Inc.股票出现波动，股价快速上涨6.03%。截至发稿，该股报1.23美元/股，成交量1.4147万股，换手率0.02%，振幅0.86%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Cytomed Therapeutics Limited较为活跃，换手率分别为427.87%、206.11%、80.33%，振幅较大的相关个股有Scisparc Ltd.、Renovaro Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 ，振幅分别为27.45%、16.20%、13.36%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223251aba088d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223251aba088d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GALT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495619898","title":"Galectin Therapeutics Inc.盘中异动 早盘快速上涨5.27%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495619898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495619898?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:30","pubTimestamp":1735655451,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时30分，Galectin Therapeutics Inc.股票出现异动，股价快速拉升5.27%。截至发稿，该股报1.16美元/股，成交量3.8924万股，换手率0.06%，振幅0.91%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，知临集团、Onconetix, Inc.、Eyenovia, Inc.涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为849.65%、617.36%、130.44%，振幅较大的相关个股有Eyenovia, Inc.、Onconetix, Inc.、Portage Biotech Inc.，振幅分别为18.27%、11.44%、10.12%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123122305295f42d10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123122305295f42d10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GALT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494394338","title":"HC Wainwright & Co.：下调Galectin Therapeutics(GALT.US)评级，由买入调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2494394338","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494394338?lang=zh_cn&edition=full","pubTime":"2024-12-28 00:51","pubTimestamp":1735318314,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：下调Galectin Therapeutics(GALT.US)评级，由买入调整至中性评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2024/12/28005146909277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GALT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494338598","title":"Galectin Therapeutics Inc.盘中异动 股价大涨5.28%报0.916美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494338598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494338598?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:31","pubTimestamp":1735309896,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时31分，Galectin Therapeutics Inc.股票出现波动，股价急速上涨5.28%。截至发稿，该股报0.916美元/股，成交量1.5589万股，换手率0.02%，振幅1.03%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Evaxion Biotech As、Vor Biopharma Inc.涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Nucana Plc较为活跃，换手率分别为69.62%、26.31%、14.49%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Evaxion Biotech As、Alumis Inc.，振幅分别为38.73%、20.04%、12.84%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227223136a20bfdee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227223136a20bfdee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GALT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492965973","title":"Galectin Therapeutics Inc.盘中异动 股价大跌5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492965973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492965973?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:46","pubTimestamp":1734446775,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时46分，Galectin Therapeutics Inc.股票出现波动，股价大幅跳水5.65%。截至发稿，该股报2.18美元/股，成交量5.361万股，换手率0.09%，振幅5.39%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722461695ea3282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722461695ea3282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491376849","title":"Galectin Therapeutics Inc.盘中异动 股价大涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491376849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491376849?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:44","pubTimestamp":1734101068,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时44分，Galectin Therapeutics Inc.股票出现波动，股价大幅拉升5.48%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Oculis Holding Ag C/Wts 06/03/2028 、Barinthus Biotherapeutics Plc涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为29.68%、23.70%、20.50%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、X4制药，振幅分别为41.44%、39.33%、24.46%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213224429984bd75a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213224429984bd75a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GALT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488946873","title":"Galectin Therapeutics Inc.盘中异动 快速下跌5.96%报2.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488946873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488946873?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:33","pubTimestamp":1733236426,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时33分，Galectin Therapeutics Inc.股票出现波动，股价快速跳水5.96%。截至发稿，该股报2.63美元/股，成交量2.7288万股，换手率0.04%，振幅5.96%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Cytomx Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为129.75%、61.86%、54.00%，振幅较大的相关个股有Coherus Biosciences, Inc.、Cabaletta Bio, Inc.、Klotho Neurosciences, Inc.，振幅分别为24.09%、12.35%、12.00%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223346a26996cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223346a26996cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482438571","title":"Galectin Therapeutics Inc.盘中异动 急速上涨5.11%报2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482438571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482438571?lang=zh_cn&edition=full","pubTime":"2024-11-09 01:35","pubTimestamp":1731087307,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日01时35分，Galectin Therapeutics Inc.股票出现波动，股价快速上涨5.11%。截至发稿，该股报2.99美元/股，成交量5.0008万股，换手率0.08%，振幅4.62%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.02%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109013508abaea4cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109013508abaea4cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GALT","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2472965608","title":"Galectin Therapeutics Inc.盘中异动 早盘急速上涨5.88%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472965608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2472965608?lang=zh_cn&edition=full","pubTime":"2024-10-04 22:54","pubTimestamp":1728053644,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日22时54分，Galectin Therapeutics Inc.股票出现异动，股价急速上涨5.88%。截至发稿，该股报2.88美元/股，成交量2.933万股，换手率0.05%，振幅5.54%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100422540498e3a9fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100422540498e3a9fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GALT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2472061157","title":"Galectin Therapeutics Inc.盘中异动 大幅拉升5.14%报2.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472061157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2472061157?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:10","pubTimestamp":1727964605,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时10分，Galectin Therapeutics Inc.股票出现异动，股价急速拉升5.14%。截至发稿，该股报2.86美元/股，成交量2.1523万股，换手率0.03%，振幅5.51%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100322100698e3a6d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100322100698e3a6d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GALT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2468502115","title":"Galectin Therapeutics Inc.盘中异动 股价大涨5.17%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468502115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2468502115?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:54","pubTimestamp":1726761279,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时54分，Galectin Therapeutics Inc.股票出现波动，股价急速拉升5.17%。截至发稿，该股报2.85美元/股，成交量3.0442万股，换手率0.05%，振幅3.69%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.64%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919235439ab64a7be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919235439ab64a7be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GALT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.galectintherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":-0.0715},{"period":"3month","weight":0.428},{"period":"6month","weight":0.202},{"period":"1year","weight":-0.0846},{"period":"ytd","weight":-0.1418}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.0227},{"period":"6month","weight":0.1061},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Galectin Therapeutics Inc.成立于2000年7月作为临制药公司，是一个发展阶段的公司，从事药物开发来为癌症和纤维化疾病创造新的疗法。格拉克缇的候选药物是基于针对半乳糖凝集素蛋白质的方法，这是生物学和病理功能的关键介质。格拉克缇采用天然存在的，随时可用的植物材料为原料，在生产过程中创造具有特定分子量和药物特性的专有复合碳水化合物。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.068623},{"month":2,"riseRate":0.714286,"avgChangeRate":0.183696},{"month":3,"riseRate":0.428571,"avgChangeRate":0.008257},{"month":4,"riseRate":0.4,"avgChangeRate":0.072934},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.029757},{"month":6,"riseRate":0.666667,"avgChangeRate":0.094875},{"month":7,"riseRate":0.466667,"avgChangeRate":0.032819},{"month":8,"riseRate":0.666667,"avgChangeRate":0.069482},{"month":9,"riseRate":0.571429,"avgChangeRate":0.009696},{"month":10,"riseRate":0.5,"avgChangeRate":-0.023176},{"month":11,"riseRate":0.357143,"avgChangeRate":-0.053714},{"month":12,"riseRate":0.214286,"avgChangeRate":-0.11026}],"exchange":"NASDAQ","name":"Galectin Therapeutics Inc","nameEN":"Galectin Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Galectin Therapeutics Inc(GALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Galectin Therapeutics Inc(GALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Galectin Therapeutics Inc,GALT,Galectin Therapeutics Inc股票,Galectin Therapeutics Inc股票老虎,Galectin Therapeutics Inc股票老虎国际,Galectin Therapeutics Inc行情,Galectin Therapeutics Inc股票行情,Galectin Therapeutics Inc股价,Galectin Therapeutics Inc股市,Galectin Therapeutics Inc股票价格,Galectin Therapeutics Inc股票交易,Galectin Therapeutics Inc股票购买,Galectin Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Galectin Therapeutics Inc(GALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Galectin Therapeutics Inc(GALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}